World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
91
Citations
29569
World Ranking
1039
National Ranking
91

Medicine

D-Index
91
Citations
29675
World Ranking
11777
National Ranking
1119

Overview

Fionula M. Brennan was affiliated with the University of Oxford in the United Kingdom. Their research primarily focused on the field of Medicine, with an emphasis on Rheumatology and Oncology as key subfields.

Their scholarly contributions included work on topics such as:

  • Rheumatoid Arthritis Research and Therapies
  • Cytokine Signaling Pathways and Interactions
  • Systemic Lupus Erythematosus Research

Brennan's publication record includes papers published in the venues Scientific Reports and Value in Health. Some notable papers included:

  • Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course, 2020, Scientific Reports
  • RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022, 2024, Value in Health

Frequent co-authors of Brennan's work included:

  • Attila A. Seyhan
  • Bernard Gregory
  • Adam P. Cribbs
  • Sundeept Bhalara
  • Yizheng Li

The research topics and collaborations suggested a focus on inflammatory and autoimmune diseases, with an emphasis on understanding molecular pathways involved in such conditions.

Best Publications

  • ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

    Marc Feldmann;Fionula M. Brennan;Ravinder N. Maini

  • Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha

    M J Elliott;R N Maini;M Feldmann;A Long-Fox

  • Evidence that cytokines play a role in rheumatoid arthritis

    Fionula M. Brennan;Iain B. McInnes

  • Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

    F M Brennan;D Chantry;A Jackson;R Maini

  • Rheumatoid Arthritis

    Unknown

  • Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

    Kim Midwood;Sandra Sacre;Anna M Piccinini;Julia Inglis

  • Immunoregulatory role of interleukin 10 in rheumatoid arthritis.

    Peter D. Katsikis;Cong Qiu Chu;Fionula M. Brennan;Ravinder N. Maini

  • TNF alpha--a pivotal role in rheumatoid arthritis?

    F M Brennan;R N Maini;M Feldmann

  • Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.

    Andrew D. Foey;Sarah L. Parry;Lynn M. Williams;Marc Feldmann

  • Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.

    A P Cope;D Aderka;M Doherty;H Engelmann

  • Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.

    Catherine Haworth;Fionula M. Brennan;David Chantry;Martin Turner

  • Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent.

    B Foxwell;K Browne;J Bondeson;C Clarke

  • Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.

    Satomichi Yoshimura;Jan Bondeson;Brian M. J. Foxwell;Fionula M. Brennan

  • Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.

    A. P. Cope;M. Londei;N. R. Chu;S. B. A. Cohen

  • Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

    Fionula M. Brennan;Claus O. C. Zachariae;David Chantry;Christian G. Larsen

  • Cytokines in autoimmunity.

    Fionula M. Brennan;Marc Feldmann

  • Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.

    Bent W. Deleuran;Cong‐Qiu ‐Q Chu;Max Field;Fionula M. Brennan

  • Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

    Jan Bondeson;Brian Foxwell;Fionula Brennan;Marc Feldmann

  • Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

    David A. Joyce;Deena P. Gibbons;Patricia Green;James H. Steer

  • Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

    Marco Londei;Corinne M. Savill;Adrienne Verhoef;Fionula Brennan

  • Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

    Ravinder N. Maini;Michael J. Elliott;Fionula M. Brennan;Richard O. Williams

Frequent Co-Authors

Marc Feldmann
Marc Feldmann University of Oxford
Brian M. J. Foxwell
Brian M. J. Foxwell Imperial College London
Ravinder N. Maini
Ravinder N. Maini Imperial College London
Andrew P. Cope
Andrew P. Cope King's College London
Richard O. Williams
Richard O. Williams University of Oxford
Martin R. Turner
Martin R. Turner University of Oxford
Ewa M. Paleolog
Ewa M. Paleolog University of Oxford
Peter C. Taylor
Peter C. Taylor University of Oxford
Peter D. Katsikis
Peter D. Katsikis Erasmus University Rotterdam
Evangelos Andreakos
Evangelos Andreakos Academy of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced nursing degrees can open doors to specialized healthcare roles. Many professionals explore acute care nurse practitioner programs to transition into roles that focus on complex patient care, which often overlaps with immunological conditions.

Accelerated study options are becoming increasingly popular for faster entry into the field. For example, accelerated NP programs allow registered nurses and non-nurses alike to quickly advance their qualifications, facilitating a quicker path to immunology-related specialties.

Non-nurses looking to enter the healthcare field can also benefit from targeted programs such as online RN programs for non nurses in Florida. These programs provide a foundation in clinical skills, enabling a future focus on immunological care and research.

For those seeking a more foundational nursing education before specializing, accelerated nursing programs offer a streamlined route to obtaining a Bachelor of Science in Nursing (BSN), which can serve as a critical step toward a career in immunology and related healthcare fields.

Best Scientists Citing Fionula M. Brennan

Recently Published Articles